Infectious Diseases Trial of a Long-Acting Malaria Drug Injection Launches in RwandaGlobal Biodefense StaffNovember 5, 2026
CBRNE Radiation Countermeasure Entolimod Clears Mouse Safety Study, Moves to Survival TestGlobal Biodefense StaffNovember 3, 2026
Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
PHEMCE Review: Accomplishments and Future Areas of Opportunity Antimicrobial Resistance March 2, 2017 …
BARDA Conducting Market Research on Ebola Medical Countermeasures Contracts + Grants February 23, 2017 …
Emergent BioSolutions to Develop Viral Hemorrhagic Fever Therapeutics Under BARDA Contract Featured News February 16, 2017 …
New Method Enables Rapid testing of Nanoparticles for Countermeasure Delivery Medical Countermeasures February 7, 2017 …
RFP – Nonhuman Primate Virology Laboratory for AIDS Vaccine Research Contracts + Grants February 6, 2017 …
Elusys Delivers Anthrax Countermeasure Order, Gains Funding for Lyophilization Effort Contracts + Grants February 2, 2017 …
NIAID-Backed Phase 1b Study to Evaluate Broad-Spectrum Antiviral for Dengue Featured News February 1, 2017 …
International Partners Work to Develop Crimean–Congo Hemorrhagic Fever Vaccine Featured News January 24, 2017 …
New Coalition for Epidemic Preparedness Sets Sights on MERS-CoV, Lassa and Nipah Medical Countermeasures January 19, 2017 …
DTRA Leveraging Approved Drugs to Expand Biodefense AMR Countermeasure Arsenal Antimicrobial Resistance January 17, 2017 …
Military Recruiting Volunteers for Human Trials of Malaria Vaccines Defense + Military January 10, 2017 …
CDC Program Helps Democratic Republic of the Congo Combat Monkeypox Biosurveillance January 10, 2017 …
PaxVax Announces Partnership with NIH and DOD for Chikungunya Vaccine Program Defense + Military January 10, 2017 …